-
Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.
Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSS
Policy & Advocacy
-
Long COVID advocacy is more than lobbying Congress: Here are some ways to get involved
-
As the American West faces increasing air pollution, protecting the right to mask is vital
-
Business school competition centers Long COVID and IACCs
-
It’s been a month. And we still don’t know much about Kennedy’s Long COVID consortium.
-
Despite the ongoing pandemic, some companies are banning employees from masking
-
Violet Affleck advocates for children with Long COVID, masks, and clean indoor air at United Nations event
Science
-
Research updates, June 9
-
Research updates, June 2
-
PolyBio’s Spring 2026 symposium: Advancing Long COVID biomarkers and treatments
-
International ME/CFS Conference roundup: Setbacks and new hopes for therapeutic research
-
Research updates, May 26
-
Mold exposure can trigger and worsen chronic illness. Climate change will increase the risk.
Covid-19
Health
-
Winter Olympic athletes are rightfully taking COVID-19 precautions
-
Long COVID affects millions of children. The largest pediatric trial so far launches this year.
-
Metrodora promised comprehensive treatment. But within two years, it abruptly closed.
-
The CDC just sidelined these childhood vaccines. Here’s what they prevent.
-
Editor’s note: An update on a recent book excerpt
-
New AI tools are helping some people manage Long COVID
-
“This exhaustion is cellular”: Excerpts from the new book ‘What Is Myalgic Encephalomyelitis Like?’
-
There’s a long history of person-first language in advocacy. Here’s why we should use it for Long COVID.
-
The (sick) kids aren’t alright: Observations from a teacher with Long COVID
-
Abandoned by our governments, people with severe ME and Long COVID are supported by severely ill peers